Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and central nervous system agents. Its structure allows for selective functionalization, making it valuable in medicinal chemistry for building complex molecules. Commonly employed in research settings to construct drug candidates targeting neurological disorders and cancer. The silyl-protected hydroxymethyl group enables controlled deprotection and further derivatization in multi-step organic syntheses.